Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 481141 - 481160 out of 493827 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level |
Price in € |
Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Bahrain | (L01EG02) everolimus (neoplastic diseases) | AFINITOR | 30, 5 MG, TABLET, 5MG , 30 | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NOVARTISPHARMAAG,SWITZERLAND. / YMH&BAHRAINPHARMACY |
| Croatia | (L04AX04) lenalidomide | Lenalidomid Teva | caps. tvrda 21x25 mg | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V. / PlivaHrvatskad.o.o.,TevaOperationsPolandSp.zo.o. |
| Croatia | (L04AX04) lenalidomide (adm: O) | Lenalidomid Teva | caps. tvrda 21x25 mg | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V. / PlivaHrvatskad.o.o.,TevaOperationsPolandSp.zo.o. |
| Norway | (L01AD01) carmustine | Carmustine Accordpharma 300 mg | , Hetteglass, Pulver og væske til konsentrat til infusjonsvæske, oppløsning, 300 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V. |
| Bahrain | (L01EA05) ponatinib (adm: O) | ICLUSIG | 30, 15 MG, FILM COATED TABLET, 15MG , 30 | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid;Leukemia, Lymphoid | TAKEDAPHARMACEUTICALSUSAINC,USA. / WAELPHARMACY |
| Australia | (L01FF05) atezolizumab | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 1200 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 1200 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 1200 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 1200 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 1200 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 1200 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 1200 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 1200 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 1200 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Germany (D) | (V03AC03) deferasirox | DEFERASIROX HEXAL 360 mg Filmtabletten | N3, 300 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
n/a | Hexal |
| Saudi Arabia | (L01ED01) crizotinib (adm: O) | XALKORI 200MG CAPSULE | 60 Bottle, 200 mg, Oral use, Capsule, hard, 200mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PFIZER / PFIZER |
| Saudi Arabia | (L01ED01) crizotinib (adm: O) | XALKORI 250MG CAPSULE | 60 Bottle, 250 mg, Oral use, Capsule, hard, 250mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PFIZER / PFIZER |
| Czech Republic | (C02KX02) ambrisentan | AMBRISENTAN ZENTIVA | 10MG, 10MG TBL FLM 30X1 I , BLJ | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s.,Praha |
| Germany (D) | (V08CA02) gadoteric acid | DOTA-MR 0,5 mmol/ml Injektionslösung i.Durchstfl. | 10X60 Milliliter, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
n/a | ConsentisDiagnostics |
| Germany (D) | (L01EG02) everolimus (neoplastic diseases) | VOTUBIA 5 mg Tabl.z.Herst.e.Susp.z.Einnehmen | N2, 30 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 10200214, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Tuberous Sclerosis | Kohlpharma |
Pages
